VALBIOTIS (EPA:ALVAL) | Finanzwire

Basculer en Français

9475	Companies
185451	Keywords
117789	Articles
99301	Press releases

Home
Companies
VALBIOTIS

BRIEF

published on 02/17/2025 at 12:05, 9 months 16 days ago

VALBIOTIS: Information on Shares and Voting Rights

Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
BRIEF

published on 02/17/2025 at 12:05, 9 months 16 days ago

Update of the shareholder structure of Valbiotis SA

Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF

published on 01/30/2025 at 17:45, 10 months 5 days ago

Valbiotis to Launch Valbiotis®PRO Metabolic Health in February

Valbiotis Metabolic Health Dietary Supplement TOTUM•63 France Launch
PRESS RELEASE

published on 01/30/2025 at 17:40, 10 months 5 days ago

VALBIOTIS SA: Valbiotis to launch its solution for the prevention of metabolic diseases, Valbiotis®PRO Metabolic Health (Totum•63), on February 3rd
Valbiotis announces the market launch of Valbiotis®PRO Metabolic Health (Totum•63) in France on February 3rd, providing a natural, plant-based solution for metabolic diseases

Valbiotis Metabolic Diseases Metabolic Health Dietary Supplement TOTUM•63
BRIEF

published on 01/21/2025 at 17:45, 10 months 14 days ago

Valbiotis Outlines 2030 Strategic and Financial Targets

Financial Targets Valbiotis International Sales 2030 Goals Cardiometabolic
PRESS RELEASE

published on 01/21/2025 at 17:40, 10 months 14 days ago

VALBIOTIS SA: Valbiotis unveils its strategic and financial goals for 2030
Valbiotis unveils its strategic and financial goals for 2030, focusing on product releases, turnover targets, and international sales expansion. Detailed roadmap and value proposition presented

Valbiotis Strategic Goals International Sales Financial Goals Product Releases
BRIEF

published on 01/14/2025 at 17:49, 10 months 21 days ago

Valbiotis Announces Success in HEART II Study on Lipidrive

Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol
PRESS RELEASE

published on 01/14/2025 at 17:44, 10 months 21 days ago

VALBIOTIS SA: Valbiotis announces the major success of the phase II/III HEART II clinical study on LIPIDRIVE
Valbiotis announces success of phase II/III HEART II study on LIPIDRIVE, proving efficacy in reducing LDL cholesterol for mild to moderate hypercholesterolemia. Study validates safety & compliance of Lipidrive

Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol
BRIEF

published on 01/08/2025 at 12:02, 10 months 28 days ago

Half-yearly report on the Valbiotis liquidity contract

Liquidity Contract PORTZAMPARC Valbiotis Sotck Exchange Stock Market Transactions
BRIEF

published on 12/17/2024 at 11:19, 11 months 19 days ago

VALBIOTIS: Monthly Information on Voting Rights and Shares

Euronext Growth Paris Voting Rights Actions Valbiotis Threshold Crossing

Accesswire

Published on 12/05/2025 at 02:35, 10 hours 7 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 10 hours 12 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 11 hours 42 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 37 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 42 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 12:05, 36 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 41 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 41 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 27 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 2 hours 11 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX

Les Echos

Published on 12/05/2025 at 08:45, 3 hours 57 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 18 hours 42 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 18 hours 57 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 18 hours 57 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 5 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE